Process for preparation of soluble guanylate cyclase stimulators
The present disclosure relates to novel processes for the preparation of compounds useful as stimulators of soluble guanylate cyclase (sGC). These processes are amenable to large scale preparation and produce stable 3-(2-pyrimidinyl)pyrazoles of Formula (I), including Compound (I), in high purity and yields. The present invention has the additional advantage of facile reaction conditions, amenable to scale up for large scale manufacturing. The disclosure also provides novel intermediates useful in the preparation of said compounds.
1. A process for preparing a compound of Formula II:
wherein:
R 1 is unsubstituted phenyl or 5 to 6-membered heteroaryl ring containing up to three ring heteroatoms independently selected from N, O or S;
R 2 is phenyl or a 6-membered heteroaryl, both optionally substituted with up to three instances of R 5 ; wherein said 6-membered heteroaryl ring contains up to 2 nitrogen ring atoms; and
each R 5 is independently selected from C 1-6 alkyl, C 1-6 alkoxy or halogen;
said process comprising the steps of:
1) mono-hydroxylating a dichloropyrimidine (7)
with an appropriate amount of sodium hydroxide, at a suitable temperature, in a suitable mixture of an aprotic and a protic solvent, in the presence of an appropriate amount of a suitable phase transfer catalyst, to afford hydroxypyrimidine (8B);
2) de-chlorinating hydroxypyrimidine (8B) with hydrogen gas or a transfer hydrogenation reagent and, optionally, an appropriate amount of a suitable metal catalyst, in the presence of an appropriate amount of a suitable base, at a suitable temperature, in a suitable organic solvent, to provide fluorohydroxypyrimidine (10);
and
3) chlorinating the alcohol of fluorohydroxypyrimidine (10) with an appropriate amount of phosphoryl chloride and optionally an appropriate amount of a suitable base, at a suitable temperature, in a suitable aprotic organic solvent.
2. The process of claim 1 , wherein the process is for preparing a compound of Formula IV
and wherein said process comprises the steps of
1) mono-hydroxylating a dichloropyrimidine (7′)
with an appropriate amount of sodium hydroxide, at a suitable temperature, in a suitable mixture of an aprotic and a protic solvent, in the presence of an appropriate amount of a suitable phase transfer catalyst, to afford hydroxypyrimidine (8′B);
2) de-chlorinating hydroxypyrimidine (8′B) with hydrogen gas or a transfer hydrogenation reagent and, optionally, an appropriate amount of a suitable metal catalyst, in the presence of an appropriate amount of a suitable base, at a suitable temperature, in a suitable organic solvent, to provide fluorohydroxypyrimidine (10′);
and
3) chlorinating alcohol (10′) with an appropriate amount of phosphoryl chloride and optionally an appropriate amount of a suitable base, at a suitable temperature, in a suitable aprotic organic solvent.
3. The process according to claim 1 , wherein R 1 is a 5-membered heteroaryl ring containing up to three heteroatoms independently selected from N, O or S.
4. The process according to claim 3 , wherein R 1 is isoxazolyl.
5. The process according to claim 4 , wherein R 1 is 3-isoxazolyl.
6. The process according to claim 1 , wherein R 2 is phenyl optionally substituted with up to three instances of R 5 .
7. The process according to claim 6 , wherein R 2 is phenyl substituted with one instance of R 5 .
8. The process according to claim 7 , wherein R 5 is halogen.
9. The process according to claim 8 , wherein R 5 is fluoro.
10. The process according to claim 7 , wherein R 2 is 2-fluorophenyl.
11. The process according to claim 6 , wherein R 2 is phenyl substituted with two instances of R 5 .
12. The process according to claim 11 , wherein each instance of R 5 is independently selected from halogen.
13. The process according to claim 12 , wherein each instance of R 5 is fluoro.